HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Evidence for HLA class II susceptible and protective haplotypes for osteomyelitis in pediatric patients with sickle cell anemia.

Abstract
We investigated the association of human leukocyte antigen (HLA) class II alleles and haplotypes with the pathogenesis of sickle cell anemia (SCA) osteomyelitis. SCA patients comprised 42 patients with osteomyelitis and 150 patients without osteomyelitis; HLA-DRB1* and HLA-DQB1* genotyping was performed by polymerase chain reaction-sequence-specific priming (SSP). DRB1*100101 (P value corrected for the number of different alleles tested, Pc=0.003) was positively associated with osteomyelitis. At the haplotype level, DRB1*100101-DQB1*050101 (Pc=0.001) was more prevalent among patients, while DRB1*030101-DQB1*0201 (Pc=0.020) and DRB1*040101-DQB1*0302 (Pc=0.039) were more prevalent among SCA controls, thereby conferring disease susceptibility or protection to these haplotypes, respectively. These results show that specific HLA haplotypes influence SCA osteomyelitis risk and that specific HLA types may serve as markers for identifying SCA patients at high risk for osteomyelitis.
AuthorsK Al-Ola, N Mahdi, A M Al-Subaie, M E Ali, I K Al-Absi, W Y Almawi
JournalTissue antigens (Tissue Antigens) Vol. 71 Issue 5 Pg. 453-7 (May 2008) ISSN: 0001-2815 [Print] England
PMID18312480 (Publication Type: Journal Article)
Chemical References
  • HLA-DQ Antigens
  • HLA-DQ beta-Chains
  • HLA-DQB1 antigen
  • HLA-DR Antigens
  • HLA-DRB1 Chains
Topics
  • Adolescent
  • Alleles
  • Anemia, Sickle Cell (genetics)
  • Child
  • Female
  • Gene Frequency
  • Genes, MHC Class II
  • Genetic Predisposition to Disease
  • Genotype
  • HLA-DQ Antigens (genetics)
  • HLA-DQ beta-Chains
  • HLA-DR Antigens (genetics)
  • HLA-DRB1 Chains
  • Haplotypes
  • Humans
  • Male
  • Osteomyelitis (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: